Koji Nakao
Director/Board Member chez JEOL LTD.
Profil
Koji Nakao currently works at Nanotis Corp., as Chairman from 2011 and JEOL Ltd., as Independent Outside Director from 2018.
Mr. Nakao also formerly worked at Terumo Corp., as Chairman.
Mr. Nakao received his graduate degree in 1970 from Keio University.
Postes actifs de Koji Nakao
| Sociétés | Poste | Début |
|---|---|---|
| JEOL LTD. | Director/Board Member | 01/06/2018 |
Nanotis Corp.
 Nanotis Corp. Medical SpecialtiesHealth Technology Nanotis Corp. engages in the research and development of rapid diagnostic devices. It plans to expand its technology through micro-chips and smartphones for the testing of SARS, MERS, Zika fever, dengue fever, and other infectious diseases. The company was founded by Lisa Sakashita and Michika Onoda on June 6, 2016 and is headquartered in Shibuya, Japan. | Chairman | 01/01/2011 |
Anciens postes connus de Koji Nakao
| Sociétés | Poste | Fin |
|---|---|---|
| TERUMO CORPORATION | Chairman | - |
Formation de Koji Nakao
| Keio University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TERUMO CORPORATION | Health Technology |
| JEOL LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nanotis Corp.
Nanotis Corp. Medical SpecialtiesHealth Technology Nanotis Corp. engages in the research and development of rapid diagnostic devices. It plans to expand its technology through micro-chips and smartphones for the testing of SARS, MERS, Zika fever, dengue fever, and other infectious diseases. The company was founded by Lisa Sakashita and Michika Onoda on June 6, 2016 and is headquartered in Shibuya, Japan. | Health Technology |
